Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study
To access this article, please choose from the options below
This study was funded in part by Taiyo, International (Minneapolis, MN, USA). The contribution by Jack F. Bukowski, M.D., was in his capacity as Nutritional Science Research Institute Director; he is also a consultant for Taiyo International.
PII: S0899-9007(08)00323-7
doi:10.1016/j.nut.2008.07.018
© 2009 Elsevier Inc. All rights reserved.
